Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cagatay Taskiran

1PUBLICATIONS

12CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 24, 2025

Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Tugan Bese, Sait Sukru Cebi, Salih Taskin

Pageof 1

Frequent Collaborators

1 joint publications

Tugan Bese

1 joint publications

Sait Sukru Cebi

1 joint publications

Salih Taskin

1 joint publications

Dogan Vatansever

1 joint publications

Firat Ortac

1 joint publications

Nedim Tokgozoglu

1 joint publications

Hasan Turan

1 joint publications

İlker Kahramanoglu

1 joint publications

Mete Gungor

1 joint publications

Faruk Kose

Frequent Collaborators

1 joint publications

Tugan Bese

1 joint publications

Sait Sukru Cebi

1 joint publications

Salih Taskin

1 joint publications

Dogan Vatansever

Top Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

See more related videos

Top Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

See more related videos